Leeds pharmaceutical company acquired

Anti-microbial technology firm Byotrol has acquired a Leeds pharmaceutical company.

The deal for Winch Pharma Consumer Healthcare is costing to the firm £70,000 with a deferred consideration of £44,000 payable in cash in 2018.

This will be subject to contract renewal by its key customer, the NHS Business Services Authority.

Byotrol said that Winch Pharma has one key asset, being a formal one year (extendable to three) contract to supply the NHSSC with non-alcohol hand sanitising products.

Prior to the acquisition, Byotrol was supplying Winch Pharma with all its hand sanitising products, which were repackaged under the Athenian brand.

David Traynor, chief executive of Byotrol plc said: “We have had a good relationship with the owners of Winch Pharma as suppliers to them of small quantities of hand hygiene products.

This transaction allows us instant and direct access to the growth in non-alcohol personal care products in the healthcare market and beyond. It also ensures that existing customers of Winch Pharma will see continuity of supply and a pipeline of high-performance, innovative new products to fit within the new biocide regulatory landscape.”